Observational study of adults with congenital heart disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the management of adult patients with congenital heart disease (ACHD) at a specialized center. It will collect clinical and epidemiological data from patients, focusing on their health outcomes, healthcare resource utilization, and quality of life. The study will involve both retrospective and prospective data collection without any additional interventions beyond standard clinical practice. The goal is to understand the natural history of ACHD and the need for future interventions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with congenital heart disease in natural history or previously undergoing palliative or corrective surgery in the time period after 14/02/2014
* Obtaining informed consent

Exclusion Criteria:

* Age \< 18 years
* Inability to obtain longitudinal data after the first follow-up performed at our Center.

Where it's running

• IRCCS Azienda Ospedaliero-Universitaria di Bologna
  Bologna, Italy Recruiting

Study contacts

• Principal investigator: Gabriele Egidy Assenza, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
• Study coordinator: Gabriele Egidy Assenza, MD
• Email: gabriele.egidyassenza@aosp.bo.it
• Phone: +390512149072

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Heart Institute Biobank and Registry for Adults with Congenital Heart Disease and Related Conditions

  This project will collect blood, tissue samples, and detailed health information from adults (≥16) with congenital heart disease and related heart or vascular conditions to create a resource researchers can use.

  Recruiting Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio · NCT07477197

• Evaluating cardiac resynchronization therapy effects in adults with congenital heart disease

  This study is trying to see if cardiac resynchronization therapy can help adults with congenital heart disease feel better and improve their heart function.

  Recruiting Leiden University Medical Center · Leiden, South Holland · NCT06969924

• Trauma, PTSD, and resilience in adults living with congenital heart disease

  This project will test whether lifetime experiences related to congenital heart disease are linked to PTSD and whether resilience helps protect adults with CHD.

  Recruiting Dartmouth-Hitchcock Medical Center · Washington D.C., District of Columbia and 2 other locations · NCT06952933

• Evaluating the effectiveness of SGLT2 inhibitors in adults with congenital heart disease

  This study is trying to see if a new type of diabetes medication can help adults with congenital heart disease feel better and manage their heart failure symptoms.

  Recruiting at 11 sites Leiden University Medical Center · Baltimore, Maryland and 10 other locations · NCT06932081

• Identifying noninvasive markers of heart transplant rejection in patients with congenital heart disease

  This study is testing a new blood test to see if it can help detect heart transplant rejection in patients with congenital heart disease without needing a more invasive procedure.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna · NCT06784440

• Evaluating long-term outcomes in adults with congenital heart disease

  This study looks at adults with congenital heart disease to see what factors might lead to serious health issues over time, while they continue their regular check-ups.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Rome, RM · NCT06723704

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.